Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05745285 · ClinicalTrials.gov registry record · NA
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
A NA study of Lymphoma and Leukemia, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 3
- Study locations
NCT05745285: Recruiting NA study of Lymphoma and Leukemia, sponsored by University of Miami.
NCT05745285 is a NA study of Lymphoma and Leukemia that is actively recruiting participants, run by University of Miami. The registered enrollment target is 400 participants, below the 482-participant average among 299 other Lymphoma trials with a reported enrollment target (17% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05745285, a NA study of Lymphoma and Leukemia, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.
Primary Outcome
Change in number of care needs will be assessed via the self-report Access to Care Survey which includes access to primary and specialty care, access to medications specific to cancer care, and access to financial resources specific to cancer care. The survey uses a composite score to assess participants' needs. Scores range from 0 to 21 with lower scores indicating better access to care needs.
Conditions Studied
Interventions
- OTHER LLS Program
Study Locations (3)
Florida
- Sylvester Comprehensive Cancer Center - Miami
Illinois
- University of Chicago Comprehensive Cancer Center - Chicago
Texas
- Mays Cancer Center at UT Health San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-02-04 |
| Est. Completion | 2026-11-01 |
| Phase | NA |
What NCT05745285 shows while recruiting
NCT05745285 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 482-participant average among 299 other Lymphoma trials with a reported enrollment target (17% lower).
The record links to 5 conditions, with Lymphoma appearing as the primary indexed condition, and to 1 intervention - of which LLS Program is the first listed.
NCT05745285 reports a single indexed study location in Florida, Illinois, Texas.
Frequently Asked Questions
What is clinical trial NCT05745285 about?
NCT05745285 is a clinical study titled "Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care". The purpose of this study is to learn about the impact that the services and programs provided by Blood Cancer United (formerly, The Leukemia and Lymphoma Society) have among patients with blood cancer, such as access to care, quality of life, and financial burden.
What is the current status of trial NCT05745285?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2025-02-04. Estimated completion is 2026-11-01.
What conditions does trial NCT05745285 study?
This clinical trial studies the following conditions: Lymphoma, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasm, Myeloma.
What interventions are being tested in trial NCT05745285?
The interventions under investigation include: LLS Program (OTHER).
Who is sponsoring clinical trial NCT05745285?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05745285 being conducted?
This trial has 3 study locations across Florida, Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lymphoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05745285's enrollment target sits among peer trials
400 22nd of 299 higher than 278 of 299 other Lymphoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lymphoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of a Communication Training Intervention for Large B-Cell Lymphoma Providers
RECRUITING · NA
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties
RECRUITING · NA
-
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
RECRUITING · NA
-
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
RECRUITING · NA
-
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI